BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$803M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
+$683M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$676M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$612M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$570M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.92B |
| 2 |
Meta Platforms (Facebook)
META
|
+$899M |
| 3 |
Amazon
AMZN
|
+$705M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$698M |
| 5 |
GE Vernova
GEV
|
+$545M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Financials | 7.92% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Healthcare | 6.49% |
| 5 | Industrials | 5.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
Standard BioTools
LAB
$280M
| $56.2K | ﹤0.01% |
61,181
-16,437
| -21% | -$19.9K |
|
|
LPBBW
4477
Launch Two Acquisition Corp Warrant
LPBBW
| $55.9K | ﹤0.01% |
358,009
| – | – |
|
|
INV
4478
Innventure Inc
INV
$135M
| $55.7K | ﹤0.01% |
14,251
+8,351
| +142% | +$29.5K |
|
|
GBFH
4479
GBank Financial Holdings
GBFH
$311M
| $55.5K | ﹤0.01% |
2,075
| – | – |
|
4480
Distribution Solutions Group
DSGR
$1.62B
| $55.3K | ﹤0.01% |
2,107
-1,322
| -39% | -$37K |
|
|
PBT
4481
Permian Basin Royalty Trust
PBT
$1.52B
| $55.3K | ﹤0.01% |
2,568
+2,118
| +471% | +$41.2K |
|
|
SBXD.WS
4482
SilverBox Corp IV Warrants
SBXD.WS
| $55.2K | ﹤0.01% |
214,539
| – | – |
|
4483
SIGA Technologies
SIGA
$216M
| $55.2K | ﹤0.01% |
10,323
-13
| -0.1% | -$81 |
|
4484
Star Group
SGU
$415M
| $55.2K | ﹤0.01% |
4,492
+1,845
| +70% | +$23.4K |
|
|
NP
4485
Neptune Insurance Holdings
NP
$4.35B
| $55K | ﹤0.01% |
+2,275
| New | +$52.6K |
|
4486
Larimar Therapeutics
LRMR
$453M
| $55K | ﹤0.01% |
12,226
-327
| -3% | -$1.31K |
|
4487
Innovative Solutions & Support
ISSC
$412M
| $55K | ﹤0.01% |
2,679
-4,271
| -61% | -$99.1K |
|
4488
Lineage Cell Therapeutics
LCTX
$271M
| $55K | ﹤0.01% |
34,810
+18,868
| +118% | +$31.8K |
|
4489
QuickLogic
QUIK
$234M
| $54.9K | ﹤0.01% |
5,851
+5,678
| +3,282% | +$46.4K |
|
|
EDN
4490
Edenor
EDN
$1.01B
| $54.6K | ﹤0.01% |
1,820
-262,588
| -99% | -$7.41M |
|
4491
ClearPoint Neuro
CLPT
$468M
| $54.6K | ﹤0.01% |
5,997
+259
| +5% | +$3.27K |
|
4492
Boston Omaha
BOC
$421M
| $54.6K | ﹤0.01% |
4,671
-7,567
| -62% | -$93.4K |
|
4493
Thryv Holdings
THRY
$96M
| $54.5K | ﹤0.01% |
19,884
+6,495
| +49% | +$25.5K |
|
4494
Norwood Financial Corp
NWFL
$376M
| $54.4K | ﹤0.01% |
1,849
-58
| -3% | -$1.7K |
|
4495
Neurogene
NGNE
$723M
| $54.3K | ﹤0.01% |
2,694
+270
| +11% | +$5.23K |
|
4496
Rezolute
RZLT
$443M
| $54.3K | ﹤0.01% |
17,803
+9,539
| +115% | +$28.6K |
|
4497
VanEck Intermediate Muni ETF
ITM
$2.13B
| $54.2K | ﹤0.01% |
1,167
+1,122
| +2,493% | +$53.1K |
|
|
NAGE
4498
Niagen Bioscience
NAGE
$239M
| $54K | ﹤0.01% |
12,256
+602
| +5% | +$3.25K |
|
|
LNKB
4499
DELISTED
LINKBANCORP
LNKB
| $53.9K | ﹤0.01% |
6,466
-899
| -12% | -$7.79K |
|
4500
Ranpak Holdings
PACK
$478M
| $53.8K | ﹤0.01% |
15,083
-5,778
| -28% | -$28.4K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Financial Markets held 6,247 positions worth $206B, down 6.7% from $221B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q1 2026 filing shows 521 new, 2,339 increased, 2,351 reduced and 443 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,501,253 shares worth $112M. The largest sale was Apple, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q1 2026 buy was Vanguard Long-Term Corporate Bond ETF: 1,501,253 shares worth $112M.
- BNP Paribas Financial Markets added most to Oracle in Q1 2026, an estimated $803M increase.
- BNP Paribas Financial Markets's biggest Q1 2026 reduction was Apple, cutting an estimated $1.92B.
- BNP Paribas Financial Markets fully exited Flutter Entertainment in Q1 2026, selling an estimated $332M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $206B portfolio in Q1 2026.
- BNP Paribas Financial Markets opened 521 new positions and closed 443 in Q1 2026.
- BNP Paribas Financial Markets's portfolio value fell 6.7% quarter-over-quarter to $206B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.